Full-Time

Event Marketing Manager

Triomics

Triomics

51-200 employees

EHR data parsing with oncology LLMs

Compensation Overview

$100k - $140k/yr

New York, NY, USA

In Person

Travel roughly twice per quarter, up to monthly, is required for events and activations.

Category
Growth & Marketing (1)
Required Skills
Sales
Lead Generation
CRM
Marketing

Get referred to Triomics

See people who can refer or advise you

Requirements
  • Experience running events and managing booths end-to-end.
  • Strong people skills and comfort starting conversations with strangers.
  • Strong project management skills, including managing logistics, vendors, budgets, and timelines.
  • Ability to hold a credible, roughly 10-minute conversation with hospital or clinical stakeholders.
  • Bias to action and ownership, with the ability to make events happen independently.
  • Willingness to travel roughly twice a quarter, up to monthly, for events and activations.
  • Strong communication and follow-through.
Responsibilities
  • Plan and run Triomics' presence at industry conferences, including booth operations, logistics, staffing, and follow-up.
  • Own Triomics-hosted events, including dinners, activations, and field events, from concept through execution.
  • Manage vendors, budgets, timelines, and other event execution details.
  • Generate and qualify leads on-site and hand them off to sales.
  • Build pre-event outreach and post-event follow-up that turns badge scans into conversations.
  • Track event performance and focus on events and formats that drive pipeline.
  • Represent Triomics credibly and warmly with clinicians and hospital stakeholders.
  • Explain what Triomics does and why it matters in concise conversations.
  • Bring field insights back to the team, including stakeholder questions and resonating messages.
  • Partner with sales and marketing to align events with pipeline goals.
  • Build a repeatable event playbook as Triomics scales its presence.
Desired Qualifications
  • SDR or lead-generation experience at conferences.
  • Experience in health tech, healthcare, or a startup.
  • Familiarity with customer relationship management and marketing or event tools.
  • A track record of tying events to pipeline.
  • Design or content skills for event collateral.

Triomics uses generative AI to turn unstructured health-record data in oncology into actionable insights. Its OncoLLM analyzes doctor notes, PDFs, and lab results to extract relevant clinical information, with Prism automating patient-to-clinical-trial matching and Harmony curating EHR data for quality reporting and cohort analysis. By integrating with existing EHR systems, it speeds up tasks that used to require hours of manual review and can match patients to trials in minutes with high accuracy. The goal is to reduce manual data review in cancer research and care, accelerate trial enrollment, and support precision oncology for cancer centers, academic medical centers, and health systems.

Company Size

51-200

Company Stage

Series B

Total Funding

$54.2M

Headquarters

New York City, New York

Founded

2020

Get referred to Triomics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Triomics raised $22 million on May 27, 2026 from Battery Ventures and existing backers.
  • MSK planned Triomics deployment in October 2025, signaling strong enterprise credibility.
  • ASCO 2025 results showed over 30% higher trial accruals using OncoLLM.

What critics are saying

  • Triomics still depends on a few marquee cancer-center deployments and partner validation.
  • Flatiron Health, Tempus, and Epic already own oncology workflow distribution channels.
  • If trial-matching accuracy slips, cancer centers will replace Triomics before 2027 renewals.

What makes Triomics unique

  • OncoLLM is oncology-specific, not generic enterprise AI, and powers PRISM trial matching.
  • Mount Sinai launched Triomics PRISM on January 8, 2026 across its cancer system.
  • Savista and Triomics launched full-stack cancer registry automation on November 4, 2025.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Flexible Work Hours

Meal Benefits

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-6%

2 year growth

-7%
TechCrunch
May 27th, 2026
Triomics nabs $22M to bring oncology-specific AI to cancer centers | TechCrunch

The Series B round was led by Battery Ventures.

SVJ Media Ltd.
May 10th, 2024
Triomics Raises $15M for AI Trials

Triomics, a generative AI startup, has secured $15M in Series A funding to enhance cancer clinical trials matching. Founded by Sarim Khan and Hrituraj Singh, the company's OncoLLM platform uses AI to quickly match patients with trials, improving efficiency in cancer care. With this funding from Lightspeed, Nexus Venture Partners, General Catalyst, and Y Combinator, Triomics plans to expand its reach and develop its platform further.

TechCrunch
May 9th, 2024
Triomics raises $15M Series A to automate cancer clinical trials matching | TechCrunch

For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each

Intelligence360 News
Mar 6th, 2023
Triomics Has Filed A Notice Of An Exempt Offering Of Securities To Raise $14,135,000.00 In New Equity Investment.

Triomics has filed a notice of an exempt offering of securities to raise $14,135,000.00 in New Equity Investment. Triomics has filed a notice of an exempt offering of securities to raise $14,135,000.00 in New Equity Investment.According to filings with the U.S. Securities and Exchange Commission, Triomics is raising $14,135,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Sarim Khan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.About TriomicsTriomics combines the most advanced clinical trial tracking software with a global network of supersites and partners to deliver rapid, cost-effective, high quality clinical trials that pass even the most rigorous regulatory scrutiny. Triomics Harmony© is powering a host of next-generation applications of healthcare data and systems for advancing clinical research by harnessing the growing maturity of US healthcare on FHIR and addressing its current limitations, enabling us to empower healthcare organizations at any phase of their FHIR adoption journey.To learn more about Triomics, visit http://www.triomics.in/Contact:Sarim Khan, Chief Executive Officer707-227-9112https://www.linkedin.com/in/sarim-khan-triomics/SOURCE: http://www.intelligence360.ioCopyright (c) 2023 SI360 Inc. All rights reserved